Nursing process applied to the patient with COVID-19 from a scoping review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i2.12741

Keywords:

Nursing; Nursing Process; Standardized Nursing Terminology; COVID-19; SARS-CoV-2; Coronavirus infection.

Abstract

Objectives: Propose the nursing process to patients infected with COVID-19 based on evidences available about the clinical features of the disease. Methodology: Scoping review performed in april 2020 on electronic databases. Were included original studies conducted with patients infected with the disease, published in portuguese, english and spanish. The studies were selected according with the reccomendation of Preferred Reporting Items for Systematic Reviews and MetaAnalyses. The sample was composed with 17 publications. Results: The detected clinical features allowed the elaboration of nursing diagnostics, results and interventions with focus on the domaines: body temperature, infection, oxigenation/respiration, cardiovascular and gastrointestinal function. Conclusion: The systems of classification NANDA International, Classifications of Nursing Outcomes and Classifications of Nursing Interventions allowed to elaborate diagnostics directed to the evaluation of progression of signs and symptoms and the interventions had as target the combat to the causes of the problems and the monitoring of the clinical conditions of the infected.

References

Alfaro-Lefevre, R. (2014). Aplicação do Processo de enfermagem: um guia passo a passo. (8a ed.), Artmed

Arksey, H., & O’Malley L. (2005). Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 8, 19-32. 10.1080/1364557032000119616

Bonow, R. O., Fonarow, G. C., O'Gara, P. T., & Yancy, C. W. (2020). Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 10.1001/jamacardio.2020.1105.

Bulechek, G. M., Butcher, H. K., & Dochterman, J. M. C. (2016). Classificação das intervenções de enfermagem (NIC). Tradução Denise Costa Rodrigues. 6.ed. Rio de Janeiro: Elsevier; 2016.

Cai, Q., Huang, D., Ou, P., et al. (2020). COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 1-11. 10.1111/all.14309.

Cao, J., Tu, W. J., Cheng, W., Lei, Y., Liu, Y. K., & Hu, X. (2020). Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infec Dis. 10.1093/cid/ciaa243

Cao, Y., Liu, X., Xiong, L., & Cai, K. (2020). Imaging and clinical features of patients with 2019 novel coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis. J Med Virol. 1-11. 10.1002/jmv.25822.

Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK554776.

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., & Wang, H. (2020) Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. 130(5), 2620-2629. 10.1172/JCI137244.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., & Han, Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 395(10223), 507-513. 10.1016/S0140-6736(20)30211-7.

Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., & Chen, G. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 368, m1091. 10.1136/bmj.m1091.

Deng, Y., Liu, W., Liu, K., Fang, Y. Y., Shang, J., Zhou, L. (2020). Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J. 10.1097/CM9.0000000000000824.

Du, R. H., Liu, L. M., Yi, W., Wang, W., Guan, L. L., & Yuan, M. L. (2020). Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China. Ann Am Thorac Soc. 10.1513/AnnalsATS.202003-225OC.

ECDC. (2020). European Center for disease prevention and control. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eighth update. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf.

El-Radhi, A. S. (2019). Pathogenesis of Fever. In: El-Radhi A. (eds) Clinical Manual of Fever in Children. Springer. 10.1007/978-3-319-92336-9_3.

Gao, Q. Y., Chen, Y. X., & Fang, J. Y. (2020). 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis. 21, 125-126. 10.1111/1751-2980.12851.

Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., & Holstein, R. (2020). Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, 1–30, 2020. Weekly. 69(15), 458-464. https://www.cdc.gov/mm wr/volumes/69/wr/mm6915e3.htm.

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. L., Ou, C. Q., & He, J. X. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 382, 1708-1720. 10.1056/NEJMoa2002032.

Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., & He, T. (2020). Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 10.1001/jamacardio.2020.1017.

Herdman, T. H., & Kamitsuru, S. (2018). Diagnóstico de enfermagem da NANDA: definições e classificação 2018-2020 / NANDA International (R. M. Garcez, Trad.). Porto Alegre: Artmed.

Inciardi, R. M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., & Tomasoni, D. (2020). Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 10.1001/jamacardio.2020.1096.

Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., & Fan, Y. P. (2020). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 7(1), 4. 10.1186/s40779-020-0233-6.

Jonhson, M., Moorhead, S., Bulechek, G., Butcher, H., Maas, M., & Swanson, E. (2012). Ligações NANDA-NOC-NIC: condições clínicas: suporte ao raciocínio e assistência de qualidade. (R. M. Garcez, & S. I. Oliveira, Trad.) (3a ed). Elsevier.

Joseph, T. (2020). International Pulmonologist’s Consensus on COVID-19. (2a ed.), https://www.saudedafamilia.org/coronavirus/artig os/international_pulmonologists_consensus.pdf.

Kunal, S.; Gupta, K.; Sharma, S. M.; Pathak, V.; Mittal, S., & Tarke, C. (2020). Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Arch Chest Dis. 90(2). 10.4081/monaldi.2020.1305.

Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., & Zhou, P. (2020). Coronavirus infections and immune responses. J Med Virol. 92, 424-432. 10.1002/jmv.25685.

Liu, K., Fang, Y. Y., Deng, Y., Liu, W., Wang, M. F., & Ma, J. P. (2020). Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 133(9), 1025-1031. 10.1097/CM9.0000000000000744.

Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., & Wang, H. (2020). Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infec Dis. 10.1093/cid/ciaa270.

Moorhead, S., Johnson, M., Maas, M., & Swanson, E. (2016). Classificação dos Resultados de Enfermagem (NOC) (A. Fernandes, Trad.) (5a ed.). Elsevier.

Oliveira, S. P., Silva, L. C. R., Silva, P. M.A., & Chianca, T. C. M. (2016). Physical methods for the treatment of fever in critically ill patients: a randomized controlled trial. Rev. esc. enferm. USP. 50(5), 823-830. 10.1590/s0080-623420160000600016.

Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., & Penninger, J. M. (2009). SARS coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 39, 618-25. 10.1111/j.1365-2362.2009.02153.x.

Pereira, A. S. et al (2018). Metodologia da pesquisa cientifica. UFSM. https://www.ufsm.br/app/uploads/sites/358/2019/02/Metodologia-da-Pesquisa-Cientifica_final.pdf

Rizzo, P., Sega, F. V. D., Fortini, F., Marracino, L., Rapezzi, C., & Ferrari, R. (2020). COVID-19 in the heart and the lungs: could we "Notch" the inflammatory storm? Basic Res Cardiol. 115(3), 31. 10.1007/s00395-020-0791-5.

Stetler, C.B., Brunell, M., Giuliano, K. K., Morsi, D., Prince, L., & Newell-Stokes, V. (1998). Evidence-based practice and the role of nursing leadership. J Nurs Adm. 28(7-8), 45-53. 10.1097/00005110-199807000-00011.

Sun, P., Qie, S., Liu, Z., Ren, J., Li, K., & Xi, J. (2020). Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta-analysis. J Med Virol. 92, 612-617. 10.1002/jmv.25735.

Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18(4), 844-847. 10.1111/jth.14768.

Tricco, A. C., Lillie, E., Zarin, W., & O'Brien, K. K. (2018), Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 169(7), 467-473. 10.7326/M18-0850.

Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., & Hu, Y. (2020). Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 10.1002/jmv.25783.

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., & Zhang, J. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 323(11), 1061-1069. doi:10.1001/jama.2020.1585.

Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., & Deng, L. (2020). Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 221(11), 1762-1769. 10.1093/infdis/jiaa150.

Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infec Dis. 10.1093/cid/ciaa272.

Wenham, C., Smith, J., & Morgan, R. (2020). COVID-19: the gendered impacts of the outbreak. Online. The Lancet. Z395-10227, 846-848. 10.1016/S0140-6736(20)30526-2.

World Health Organization. (2020). Coronavirus disease (COVID-19) situation Report -119 WHO. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200518-covid-19-sitrep-119.pdf?sfvrsn=4bd9de25_4.

World Health Organization. (2020). State of the World’s Nursing Report – 2020. WHO [Internet]. https://www.who.int/publications-detail/nursing-report-2020.

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., & Guo, Q. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 94, 91–95. 10.1016/j.ijid.2020.03.017.

Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., & Pan A. (2020). Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 80(4), 388-393. 10.1016/j.jinf.2020.02.016.

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., & Liu, H. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 8, 475-81. 10.1016/S2213-2600(20)30079-5.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., & Liu, Z. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 11(20), 30566-3. 10.1016/S0140- 67

Published

28/02/2021

How to Cite

MELO, Érik C. A. de; NORONHA, J. A. F.; SANTOS, S. M. P. dos .; BARBOSA NETO, J. H.; SILVA, M. A.; OLIVEIRA, T. L. de. Nursing process applied to the patient with COVID-19 from a scoping review. Research, Society and Development, [S. l.], v. 10, n. 2, p. e53810212741, 2021. DOI: 10.33448/rsd-v10i2.12741. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/12741. Acesso em: 23 apr. 2024.

Issue

Section

Review Article